ArticleBlood advances2026
Ford JG, Koh MJ, Lenart AW, et al. Real-world evidence of duvelisib and romidepsin in relapsed/refractory peripheral and cutaneous T-cell lymphomas. Blood Adv. 2025;9(16):4286-4305.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.